A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention

A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention

Abstract Optimal antiplatelet therapy after endovascular therapy (EVT) for peripheral artery disease is controversial. This trial aimed to evaluate whether sarpogrelate plus aspirin was non-inferior for preventing early restenosis after femoropopliteal (FP) EVT compared to clopidogrel plus aspirin....

Full description

Bibliographic Details
Main Authors: Ahram Han, Taeseung Lee, Joongyub Lee, Suk-Won Song, Sang-Su Lee, In Mok Jung, Jin Mo Kang, Jun Gyo Gwon, Woo-Sung Yun, Yong-Pil Cho, Hyunmin Ko, Yang-Jin Park, Seung-Kee Min
Format: Article
Language:English
Published: Nature Portfolio 2023-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-29006-z

Internet

https://doi.org/10.1038/s41598-023-29006-z

Similar Items